Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XueZhiKang in Hyperlipidemia
NCT01327014Phase 2Completed
- Sponsor
- Peking University WBL Biotech
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Xuezhikang in hyperlipidemia, sponsored by Peking University WBL Biotech. Started Apr 2011; status: completed.
02
Drugs
Xuezhikang
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT01327014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327014.